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Deborah L. Birx,¶ Donald S. Burke,# 
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HIV-1 is an immunosuppressive pathogen. Our behav-
ioral data for 191 HIV-1–infected rural Cameroonians show 
frequent exposure to nonhuman primates through activi-
ties such as hunting and butchering. Immunosuppression 
among persons exposed to body fl uids of wild nonhuman 
primates could favor the process of adaptation and subse-
quent emergence of zoonotic pathogens.
Worldwide, ≈1% of the population is immunodefi cient. Although immunodefi ciency has numerous causes, 
such as malnutrition or iatrogenic medical therapies for 
cancer and organ transplantation, the most signifi cant factor 
globally is HIV-1 infection (1). In 2006, ≈40 million persons 
were infected with HIV-1, and >50% were in sub-Saharan 
Africa, where AIDS caused 2.1 million deaths (2).
Immunodefi ciency resulting from HIV-1 infection 
renders the host susceptible to infections usually controlled 
by cellular immunity through unrelenting loss of CD4+ 
T-helper lymphocytes. This susceptibility predisposes af-
fected persons to common disease-causing pathogens such 
as Mycobacterium tuberculosis, Salmonella spp., Coccidi-
oides spp., and Histoplasma spp. Other pathogens that are 
rarely pathogenic for immunocompetent persons, such as 
Cytomegalovirus, human herpesvirus-8, Pneumocystis 
spp., Cryptococcus spp., and M. avium complex, also be-
come common causes of disease.
HIV-1–induced immunosuppression has also been 
proposed as a factor affecting the global emergence and 
reemergence of diseases (1,3). Among emerging infectious 
diseases in humans, ≈75% are caused by zoonotic patho-
gens (4), highlighting the potentially important risk for zoo-
notic exposures for HIV-1–infected populations. Central 
African forests, where hunting and butchering nonhuman 
primates are common practices, provide a ripe environment 
for zoonotic transmission (5). These areas have fostered 
human acquisition of Ebola (6,7), monkeypox (8), simian 
immunodefi ciency viruses (9), simian foamy viruses (10), 
and primate T-lymphotropic viruses (11). Because HIV-1 
infection is epidemic in Africa, persons involved in hunt-
ing and butchering of wild animals (including nonhuman 
primates) are possibly HIV-1–infected and thus at risk for 
successful infection with novel zoonotic viral infections. 
Additionally, HIV-1–induced immunosuppression in the 
wider community poses an additional risk for secondary 
transmission that could facilitate early viral adaptation to 
humans (12).
The Study
As part of a community-based HIV-1 prevention cam-
paign, February 2001–January 2003, we collected oral 
questionnaire data about basic demographics and behav-
ior associated with exposure to the blood or body fl uids 
of wild animals. In addition, blood samples were collected 
and transported to a central laboratory for HIV testing. We 
present behavioral data pertaining to animal exposures of 
HIV-1–infected persons in 17 rural villages in Cameroon 
(5). These are key sites for the emergence of nonhuman 
primate retroviruses because of the high levels of human 
contact with wild nonhuman primates (5) and cross-spe-
cies transmission of simian foamy virus (10) and primate 
T-lymphotropic viruses (11).
Study participation was voluntary and performed un-
der a protocol approved by the Johns Hopkins Committee 
for Human Research, the Cameroon National Ethical Re-
view Board and the HIV Tri-Services Secondary Review 
Board. A single project assurance was obtained from the 
Cameroonian Ministry of Health and accepted by the Na-
tional Institutes of Health Offi ce for Protection from Re-
search Risks.
HIV testing was performed by using an ELISA/West-
ern blot algorithm. The ORTHO HIV1/2 (ORTHO Clinical 
Diagnostics Gmbh, Neckargemünd, Germany) ELISA was 
used as the screening test, and the HIV Blot 2.2 (Genelabs 
Diagnostics, Singapore) Western blot assay was used for 
confi rmation.
Complete questionnaire data and plasma samples were 
collected from 3,955 persons, of whom 46.3% were fe-
male and 53.7% were male. Age range was 16–97 years 
(42% 16–30, 27% 31–45, 21% 46–60, and 10% >60 years). 
Screening for HIV-1 infection found 191 seropositive per-
sons (prevalence 4.8% overall, 1.9%–16.3% from the 17 
sites), of whom 60.2% were female and 39.8% were male. 
No persons were HIV-2 seropositive.
The HIV-1–infected persons were examined in greater 
detail. Within the younger age group (16–30 years), wom-
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en were overrepresented; among persons >30 years of age, 
the number of infected men and women was similar (Figure 
1). Of the HIV-1–infected persons, 89.0% reported having 
lived in a major city or another country, compared with 
82.8% of the HIV-negative study population). Agricultural 
activities were reported as daily activities by 46.6% of the 
HIV-1–positive persons; household activities, by 22.0%; 
and fi shing, by 13.6%. Hunting was reported as a daily ac-
tivity by 12.6%, and contact with wild animals was report-
ed by an even higher proportion. Among HIV-1–positive 
persons, 79.6% reported butchering wild animals (as many 
as 20× per month), 26.2% reported hunting wild animals 
(also as many as 20× per month), 12.6% reported having 
kept a wild animal as a pet, and 95.8% reported eating wild 
animals (Figure 2).
HIV-1–infected persons had signifi cant contact with 
nonhuman primates; hunting of these species was reported 
by 11.0%. Monkeys were hunted up to 10× per month (me-
dian 3× per month); chimpanzees and gorillas were hunted 
less frequently (always <1× per month). In terms of butch-
ering, 55.5% reported butchering nonhuman primates: 
monkeys <10× per month (median 1× per month), chim-
panzees 2× per month (median <1× per month), and goril-
las <1× per month. Furthermore, 8.4% of HIV-1–infected 
persons reported keeping nonhuman primates as pets, and 
83.8% reported eating nonhuman primates.
Other direct animal exposures were reported by HIV-
1–infected persons (Table); bites or scratches from wild 
animals were reported by 12.0% and from nonhuman pri-
mates by 2.6%. Although 4.7% of persons reported hav-
ing received injuries during hunting and butchering, none 
reported having received injuries during hunting or butch-
ering of nonhuman primates. However, 1.7% of the rural 
population in this area reports such injuries (5).
Conclusions
These data demonstrate an overlap of areas where 
HIV-1 is epidemic and areas where human-nonhuman pri-
mate contact is common. This overlap is cause for concern 
because humans and nonhuman primates share susceptibil-
ity to a range of pathogens, and the potential for successful 
cross-species transmission from nonhuman primates to hu-
mans is considered great (5). Access to treatment for HIV-
1 infection is improving but is limited in remote central 
African communities; progressive disease and immunosup-
pression develop in most persons in these areas. Exposure 
of immunocompromised persons to nonhuman primates 
poses ongoing opportunities for zoonotic viruses to leap 
to humans, and the high concentration of other immuno-
compromised hosts offers an increased risk for secondary 
transmission and adaptation to humans. The emergence of 
HIV-1 is an example of such a process; data suggest sev-
eral abortive nonhuman primate-to-human transmission 
events before eventual establishment of the HIV pandemic. 
This foothold gained by HIV-1 may now offer a boost for 
other pathogens to enter the human population. Moreover, 
the prevalence of HIV-1 in rural areas is lower than that 
in adjacent urban communities in Cameroon (13) and may 
increase. Such circumstances are not limited to central Af-
rica; recent reports from Asia have demonstrated the risk 
for zoonotic infections with nonhuman primate viruses 
(14,15). And although nonhuman primates may present 
particular risks for disease emergence, HIV-associated im-
munosuppression likely increases the risk for acquisition, 
adaptation, and emergence of zoonoses infecting other 
animals that are hunted extensively in these communities 
(Figure 2), such as monkeypox and hantaviruses in rodents 
and Lyssavirus in bats.
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Figure 1. Age distribution of HIV-positive persons in 17 rural villages 
in Cameroon.
Figure 2. Percentage of HIV-positive persons in 17 rural villages 
in Cameroon who reported different types of contact with all wild 
animal species and with nonhuman primates.
Exposure to Wild Primates among HIV-infected Persons
The risk for emergence of novel zoonotic infections in 
rural hunting communities should be considered in health-
care policy. Community health education and HIV/AIDS 
counseling should account for the fact that many persons 
in these communities rely on wild animals for food and 
household income. Targeted interventions could include 
culturally appropriate suggestions for avoiding handling 
or butchering of wild animals, such as developing alterna-
tive food sources, or taking precautions if such activities 
are necessary. Reducing the prevalence of HIV-1–induced 
immunosuppression through prevention and treatment and 
minimizing zoonotic exposures will be crucial for prevent-
ing future outbreaks of novel viral pathogens in humans.
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